Unraveling the Effects of Hexametaphosphate: Insights into Trypsin Aggregation and Structural Reversal Authors: Ajamaluddin Malik, Abdulaziz Alamri, Nojood Altwaijry, Abir Alamro, Abdullah Alhomida, Rashid Ayub, Hamza Odeibat Published: 2024 ABSTRACT Elevated serum phosphate levels have been linked to increased mortality rates. This study investigated the effect of millimolar (mM) concentrations of sodium hexametaphosphate (SHMP) on trypsin’s aggregation and structural stability at intestinal pH levels. We used various spectroscopic and microscopic techniques to investigate the structural changes of trypsin aggregates. Turbidity and light scattering results revealed that trypsin aggregates began to solubilize at SHMP concentrations above 1 mM, with maximum solubilization observed at 6 mM SHMP. Intrinsic, thioflavin T (ThT) fluorescence, and far-UV CD spectra indicated that trypsin amorphous aggregates turn into native-like structures in the presence of 6 mM SHMP. Transmission electron microscope (TEM) imaging also showed the disappearance of amorphous aggregates at higher SHMP concentrations. This study showed that higher SHMP concentrations solubilized the trypsin aggregates and induced a native-like conformation. These findings highlighted that SHMP could be a good protein aggregate solubilizer, with future applications in inclusion body solubilization and protein refolding. Introduction Comprehensive epidemiological studies showed a correlation between hyperphosphatemia and increased mortality. Additionally, hyperphosphatemia is associated with elevated risks of cardiovascular events and mortality in the general population.1−3 As a result, phosphate intake through food is a concern for everyone.4 Research indicates that even young persons who are healthy may experience negative effects from phosphate additives in food.5,6 Phosphates are naturally present in foods as organic esters, which cannot be removed and are absorbed by the body through a complex digestive process. The gastrointestinal tract can absorb only about 40–60% of these naturally occurring phosphates.3,7 In contrast, free inorganic phosphates, commonly used as food additives, are rapidly absorbed into the gastrointestinal tract. These additives—such as monophosphate, diphosphate, triphosphate, and hexaphosphate salts (E 339, E 450, E 451, and E 452)—serve various roles in the food industry, including as preservatives, stabilizers, acidity regulators, and emulsifiers.8,9 The absence of clear phosphate content labeling on processed foods exacerbates the issue. Inorganic phosphates are prevalent additives in processed foods, especially in processed cheese, animal products, bread, and beverages. These additives increase the phosphate content of processed foods compared with their natural counterparts. Inorganic phosphates are favored in industrial food processing due to their low cost and ability to enhance processed foods’ texture, shelf life, and functionality.9 Sodium hexametaphosphate (SHMP), a synthetic additive, is frequently used to improve the texture and quality of foods by acting as an adhesive, swelling reagent, and chelating agent for metal ions.10−12 In food processing, phosphates are added to enhance water retention and improve the meat product stability and protein structure. Adding phosphates to the food is done to loosen the protein structure and enables the protein to bind and retain more water.13−16 Excessive use of phosphates in soft drinks is also common to prevent the formation of harmful glycation end products.17,18 There is a growing concern about the potential harm caused by the widespread use of inorganic phosphates in processed foods, especially as phosphate consumption has risen from less than 500 mg to over 1000 mg per day over the last three decades.19−21 The general public and policymakers need to be aware of the potential harm of phosphate additives. Elevated serum phosphate levels are significantly linked to higher mortality rates.1−3 While dialysis patients are particularly at risk of cardiovascular disease due to elevated phosphate levels, similar risks have been observed in individuals with partial kidney impairment and even in healthy people.5,6,22 Observational studies show that for every 1 mg/dL increase in blood phosphate levels, there is a 22% rise in mortality risk, underscoring the need for everyone to reduce phosphate consumption.22 Phosphate consumption is increasing regularly in processed foods; therefore, it is urgent to understand the interaction mechanism between polyphosphates and important proteins such as digestive enzymes. In a prior investigation, the impact of micromolar concentrations of SHMP on trypsin aggregation propensity was assessed.23 It was found that trypsin, a digestive enzyme, undergoes denaturation and subsequent aggregation when exposed to concentrations of SHMP above 10 μM. This study aimed to investigate the effects of higher SHMP concentrations, specifically in the millimolar range, on trypsin’s aggregation and conformation under physiological conditions that mimic the pH levels of the digestive tract. In the human duodenum, for example, the pH is roughly 6, which gradually increases along the small intestine, reaching a pH of 7.4 in the ileum, then drops to 5.7 in the cecum and eventually stabilizes at around 6.7 in the rectum.24 The calculated isoelectric point of trypsin was 8.69. At a pH of 6.0, it has 14 protonated lysine residues and 2 protonated arginine residues. Based on Protein Calculator version 3.4 calculations, the overall charge of trypsin at this pH is +8.5, indicating that trypsin is positively charged at pH 6.0. Through spectroscopic and microscopic techniques, we aim to deepen our understanding of how higher concentrations of SHMP influence the structure and solubility of digestive enzymes. By elucidating the mechanisms underlying this aggregation suppression or solubilization process, we seek to address the interaction mechanism between phosphates and digestive enzymes. Ultimately, this research work sheds light on the intricate interplay between polyphosphates and trypsin and holds promise for developing strategies to ensure the safety and efficacy of processed food products. Materials and Methods We used bovine trypsin (Cat. # T8003; ∼10,000 BAEE units/mg protein), SHMP (Cat. # 305553; 96% purity), and thioflavin T (Cat. # T3516; dye content, 65%) from Sigma Chemical Company, USA. All of the solutions were made with Milli-Q water and then filtered through 0.22 μm. All other reagents that were utilized in this study were of analytical grade. Sample Preparation A solution containing bovine trypsin was prepared by dissolving 10 mg of the trypsin in 5 mL of 1 mM hydrochloric acid. To quantify the amount of bovine trypsin present, its absorbance at 280 nm was measured using spectrophotometry using an extinction coefficient (E1%) of 15.4.23 The bovine trypsin sample aliquots were stored at −20 °C. A fresh stock solution of 100 mM SHMP was also prepared in Milli-Q water. Effect of SHMP on Trypsin Solubility Various concentrations of SHMP, ranging from 1 to 20 mM, were added to a solution of bovine trypsin (8.4 μM) in 20 mM phosphate buffers, pH 6.0. In order to inhibit autolysis, trypsin samples treated with SHMP were incubated on ice for 2 h at pH 6.0. Turbidity Measurements The opacity of bovine trypsin (8.4 μM) treated with 1–20 mM SHMP was assessed at 350 nm. The SHMP-treated trypsin samples were placed in a 10 mm path length cuvette. The absorbance of the samples was measured by using an Agilent Technologies Cary 60 UV–visible spectrophotometer. Rayleigh Light Scattering Kinetics A Rayleigh light scattering (RLS) kinetics study was conducted to examine the rate of SHMP-induced trypsin solubility at pH 6.0. A stirrer linked with a Cary Eclipse fluorometer was employed to examine the RLS kinetics in the presence of 1 mM SHMP in a 1.0 cm path length cuvette. The bovine trypsin concentration was fixed at 8.4 μM. The RLS intensity was measured over time at 350 nm by using a cuvette with a magnetic bar. The excitation and emission wavelengths were consistently set at 350 nm and slit widths at 1.5 and 2.5 nm, respectively. Initially, the RLS kinetics were measured for 120 s in the presence of SHMP. Subsequently, a solution containing 9 mM SHMP was added, and measurements were recorded for an additional duration of 250 s. Subsequently, 10 mM SHMP was added, and data was collected for 120 s. SHMP-Induced Tertiary Structural Changes Trypsin samples treated with SHMP were analyzed at ambient temperature (20 °C) using a Cary Eclipse spectrofluorometer to determine any alterations in the intrinsic tryptophan fluorescence. The bovine trypsin (8.4 μM) was treated with 1 to 20 mM SHMP at pH 6.0. To observe changes in the environment surrounding the tryptophan residues, trypsin samples were excited at 295 nm. The emission spectra were acquired within the 300–400 nm wavelength range. For this experiment, the excitation slit and the emission slit were set at 5 nm. SHMP-Induced Secondary Structural Changes The experiment employed Chirascan Plus spectropolarimeters to measure the far-UV CD of trypsin samples treated with 1–20 mM SHMP at pH 6.0. Measurements were conducted using a cuvette with a path length of 0.1 cm, between 200 and 250 nm at 20 °C. The trypsin concentration remained constant at 8.4 μM in each sample. SHMP blanks of different concentrations were used to eliminate interference from the spectra. ThT Fluorescence Measurement After the ThT stock solution was prepared in Milli-Q water, it was passed through a 0.22 μm filter. The concentration of ThT was determined using a molar extinction coefficient of 36,000 M–1 cm–1 at 412 nm.25 To determine the presence of amyloid fibrils, trypsin samples (8.4 μM) treated with 1–20 mM SHMP were used, and after adding 10 μM of ThT to each sample, 30 min incubation was done in the dark. The emission of ThT was measured by excitation of samples at a wavelength of 440 nm. The emission spectra were measured in the 450–600 nm wavelength range. In this experiment, the slit widths were set at 5.0 nm for both excitation and emission. Furthermore, experiments were carried out to examine the ThT kinetics of trypsin caused by SHMP at a pH of 6.0 under identical conditions. TEM Imaging of SHMP-Induced Trypsin Samples At a 120 kV accelerating voltage, TEM imaging of trypsin samples was done using a JEOL 1400 transmission electron microscope. To examine the effect of SHMP on the trypsin, 10 μL of trypsin samples (8.4 μM) that were treated with 1 and 10 mM SHMP were used for TEM imaging. A copper grid with a mesh size of 200 mm was used to prepare the samples for imaging. The grids were washed and treated for two min with a negative stain containing 2% uranyl acetate. The grid was dried before imaging. Results Concentration-Dependent Solubilization of Trypsin by SHMP Our previous investigation found that SHMP in the micromolar range (10–200 μM) induced trypsin aggregation, and the turbidity remained consistent up to 1.0 mM SHMP.23 This study examined the impact of millimolar concentrations of SHMP on trypsin’s solubility and structural changes at intestinal physiological pH. Figure 1 illustrates the turbidity data at 350 nm. The turbidity of trypsin exhibited a linear decrease between 1.0 and 6.0 mM SHMP, with a baseline observed up to 20.0 mM SHMP. The turbidity of untreated trypsin and trypsin treated with 6 mM SHMP or higher concentrations appeared similar. The findings indicated that trypsin aggregates formed in the presence of 1.0 mM SHMP, which linearly decreased up to 6.0 mM SHMP. At higher SHMP concentrations, trypsin remained soluble, similar to untreated trypsin. Aggregate solubilization of trypsin in the presence of a millimolar concentration range of SHMP. At 350 nm, the turbidity of trypsin (8.4 μM) treated with 1.0–20.0 mM SHMP at pH 6.0 is shown by black circles. Red triangles show the turbidity of the control sample (untreated trypsin). Blue squares show the turbidity of 1–20 mM SHMP (control samples). Effect of SHMP on Tertiary Structure Trypsin contains four tryptophans, which are principally responsible for its intrinsic fluorescence. Changes in the microenvironment surrounding tryptophan, induced by various factors such as ligand binding, pH and temperature changes, or other stressors, resulted in changes in the intrinsic fluorescence intensity.26,27 In this study, the fluorescence spectra of trypsin were examined in both the absence and presence of 1.0–20.0 mM SHMP. The samples were excited at 295 nm, and the fluorescence intensity was measured within the range of 300–400 nm. As shown in Figure 2, it was observed that the wavelength maxima of untreated and SHMP-treated trypsin were the same (i.e., at 332 nm) at pH 6.0. Furthermore, it was noted that the fluorescence intensity exhibited a linear increase with SHMP concentration ranging from 1.0 to 6.0 mM. Interestingly, within this concentration range, there was a decrease in the trypsin turbidity, as shown in Figure 1. Intrinsic fluorescence of untreated and SHMP-treated trypsin. Intrinsic fluorescence spectra of 8.3 μM trypsin and 8.3 μM trypsin treated with 1.0–20.0 mM SHMP at pH 6.0. The fluorescence spectra of the 20 mM SHMP alone (control sample) are displayed with red dots. Different colors and lines (solid, dashed, and dotted) are used to distinguish the spectra of different SHMP concentrations. The inset shows the fluorescence intensity of trypsin without (red square) and with (blue circle) different SHMP concentrations at pH 6.0. Effect of SHMP on Secondary Structure Far-UV circular dichroism (CD) is an effective method for determining the secondary structure of proteins.28 Earlier studies23,29 demonstrated that far-UV CD spectra of trypsin showed a single minimum at 208 nm. In this study, far-UV CD spectra of untreated trypsin at pH 6.0 exhibited a characteristic minimum at 208 nm (Figure 3). However, the presence of 1.0 mM SHMP led to the disappearance of the ellipticity minima at 208 nm, indicating a loss of secondary structure. Interestingly, as the concentration of SHMP increased to 6.0 mM, the ellipticity minima were gradually regained at 208 nm, suggesting a regain of the secondary structure. Similarly, changes in turbidity and intrinsic fluorescence were also observed in similar fashion (Figures 1 and 2). Further increases in SHMP concentration, ranging from 6 to 20 mM did not lead to notable changes in the secondary structure. Despite the increased negative ellipticities, the overall shape of the far-UV CD spectra remained similar to that of untreated trypsin. Our investigation also suggested a correlation between the solubility propensity of trypsin and the gain of secondary structure. Our findings indicated that within the millimolar range, SHMP facilitates the acquisition of secondary structures in trypsin, while in the micromolar range, it results in the loss of secondary structure.23 The impact of milimolar concentrations of SHMP on the far-UV CD spectra of trypsin. The far UV-CD spectra of trypsin treated with 0 to 20 mM SHMP were recorded in the 200–250 nm range. The trypsin concentration was fixed at 8.4 μM throughout the experiments. The inset figure shows the changes in ellipticity at 208 nm with respect to SHMP concentrations. The red square in the inset figure represents the ellipticity of untreated trypsin at 208 nm. SHMP-Dependent ThT Fluorescence Thioflavin T (ThT) dye in its aqueous state exhibits negligible fluorescence. When ThT interacts with β-sheets of amyloid fibrils, the fluorescence intensity increases over 10-fold30 while ThT binding to amorphous aggregates results in a 3- to 5-fold increase in fluorescence intensity.31 Consequently, the ThT assay is commonly employed to identify amyloid fibrils within the aggregates. In this study, ThT fluorescence was utilized to characterize the SHMP-induced aggregates. The ThT signal exhibited a gradual decrease in a concentration-dependent manner when the SHMP concentration was raised from 1 mM to 6 mM (Figure 4). The nearly 3-fold increase in ThT fluorescence observed in untreated trypsin and trypsin treated with 1 mM SHMP suggests the absence of amyloid-like structures in the aggregates. The gradual changes in ThT fluorescence between 1 mM and 6 mM SHMP corresponded to changes in solubility (Figure 1), tertiary structure (Figure 2), and secondary structure (Figure 3) of the trypsin samples. SHMP-dependent ThT fluorescence of trypsin at pH 6.0. ThT fluorescence of trypsin at pH 6.0 was assessed in the presence of varying concentrations of SHMP. Spectra were collected between 450 and 600 nm following excitation at 440 nm, with ex and em slits set at 5 nm. The inset graph shows changes in ThT fluorescence at 485 nm corresponding to different SHMP concentrations. The red square in the inset graph indicates the ThT fluorescence observed in untreated trypsin at 485 nm. RLS Kinetics of SHMP-Treated Trypsin At an intestinal physiological pH of 6.0, the RLS kinetics of 8.4 μM trypsin treated with SHMP was investigated. Figure 5 showed the kinetic profiles of trypsin samples treated with various SHMP concentrations ranging from 1 to 20 mM. When 1 mM SHMP was present, trypsin aggregated, resulting in an RLS value exceeding 100 A.U. Upon the addition of 9 mM SHMP to a 3 mL sample containing a magnetic bar, the RLS values immediately decreased, almost reaching baseline levels, indicating the rapid dissolution of trypsin aggregates at 10 mM SHMP. As trypsin aggregates were nearly completely dissolved at 10 mM SHMP, further addition of 10 mM SHMP resulted in a slight decrease in RLS. The RLS kinetics pattern indicated that the solubilization process had no lag phase. SHMP-induced solubilization kinetics of trypsin at pH 6.0. The RLS kinetics at a concentration of 8.4 μM trypsin were measured at 350 nm, with the intermittent introduction of SHMP. Following 120 s, 9 mM SHMP was introduced, and the changes in RLS were recorded. Upon the addition of 9 mM SHMP, there was an instant decrease in RLS intensity, reaching a plateau shortly thereafter. Effect of SHMP on ThT Kinetics A ThT fluorescence dye was employed to study the binding kinetics of ThT within SHMP-induced aggregates (Figure 6). A trypsin sample treated with 1 mM SHMP was used as a reference point. Changes in ThT fluorescence intensity after the addition of 9 mM SHMP showed an immediate decrease in ThT fluorescence, characterized by an absence of a lag-phase. Within a few seconds, the ThT fluorescence reached a stable baseline plateau. ThT kinetics of trypsin treated with different concentrations of SHMP at pH 6.0. ThT dye (10 μM) was added in 3 mL to trypsin samples (8.4 μM) treated with 1 mM SHMP. The ThT kinetics were recorded at 485 nm at 20 °C. When 9 mM SHMP was added, ThT fluorescence decreased immediately and reached a plateau within a few seconds. TEM Imaging of SHMP-Treated Trypsin Samples Transmission electron microscopy (TEM) was employed to examine the effects of SHMP on trypsin samples at a high resolution (Figure 7). At a pH of 6.0, trypsin treated with 1 mM SHMP formed aggregates; however, the presence of 10 mM SHMP at the same pH led to the solubilization of these aggregates. The TEM analysis revealed the presence of amorphous-like aggregates in the trypsin samples treated with 1 mM SHMP, whereas these aggregates disappeared in samples treated with 10 mM SHMP. These TEM findings corroborate the observations made through turbidity measurements, far-UV CD, and ThT measurements. TEM images of SHMP-treated trypsin samples. Trypsin (8.4 μM) was treated with 1 mM (A) and 10 mM (B) SHMP at pH 6.0. Discussion In this study, we found that the trypsin aggregation starts diminishing above 1 mM SHMP concentration and aggregates were diminished above 6 mM SHMP concentrations (Figure 1). Fluorescence spectroscopy showed a direct link between trypsin tertiary structure change and SHMP concentration of 1.0–6.0 mM (Figure 2). Turbidity decreased in the same concentration range. These results indicated a close association between the tertiary structural changes and turbidity, which are indicative of the aggregate solubilization process. The decrease in turbidity within the same concentration range suggested that the aggregation of trypsin was reduced as SHMP concentrations increased. SHMP and other small molecules were found to solubilize the aggregates in the presence of their higher concentrations.32,33 Further structural analysis using far-UV circular dichroism (CD) spectroscopy showed that untreated trypsin exhibited a characteristic minimum at 208 nm, indicative of its α-helical secondary structure. However, the addition of 1.0 mM SHMP led to loss of this minimum, indicating a loss of secondary structure due to aggregation of the trypsin sample (Figure 3). Interestingly, increasing SHMP concentration to 6.0 mM gradually restored the ellipticity at 208 nm, indicating a gain of secondary structure and solubilization of aggregates. Our far-UV CD results showed that the spectral peak position at 208 nm was regained and remained fixed at higher SHMP concentrations, which indicated that trypsin aggregates were solubilized and secondary structure was not further altered. As we know, if the protein is having an amyloid-like structure, then far-UV CD gives a peak at 215 nm and higher wavelenths.32,34,35 But, in our case, we did not observe a peak at 215 nm or at higher wavelengths, which confirmed that amyloid-fibril formation was not present in trypsin samples. The study also employed a ThT fluorescence assay commonly used to detect amyloid fibrils and other beta-sheet-rich structures.36,37 ThT fluorescence decreased proportionally with an increase in SHMP concentrations from 1 to 6 mM (Figure 4). Trypsin treated with 1 mM SHMP showed only a 3-fold increase in ThT fluorescence, indicating the absence of amyloid-like aggregates and the presence of amorphous aggregates (Figure 4). When exposed to 1 mM SHMP, trypsin aggregated, resulting in RLS levels above 100 A.U. However, the addition of 9 mM SHMP quickly disintegrated trypsin aggregates to the starting levels. More SHMP reduced RLS slightly, suggesting solubilization (Figure 5). When 9 mM SHMP was added to SHMP-induced aggregates, the ThT fluorescence decreased immediately. Rapid aggregate disintegration was shown by this reduction, reaching a stable baseline plateau within seconds (Figure 6). TEM validated our findings, showing amorphous aggregates in trypsin samples treated with 1 mM SHMP. When the samples were treated with 10 mM SHMP, no such aggregates were observed, confirming the disaggregation of trypsin (Figure 7). The concentration-dependent effect of sodium hexametaphosphate (SHMP) on trypsin aggregation is primarily due to its negatively charged phosphate groups. These phosphate groups may interact with proteins through various salt-related mechanisms.38−40 As a kosmotropic agent, SHMP stabilizes proteins by structuring water molecules around them, promoting proper folding.41 When proteins like trypsin denature, exposed hydrophobic regions drive aggregation through hydrophobic interactions.42 SHMP reduces this by shielding these regions and minimizing aggregation. At higher concentrations, SHMP’s charge–charge repulsion stabilizes trypsin, preventing aggregation or even disassembling existing aggregates. The exact mechanism by which polyphosphates influence protein aggregation is complex and depends on various factors including the type of protein, the length of the polyphosphate chain, and the solution conditions. In summary, SHMP prevents trypsin aggregation and stabilizes the protein through charge–charge repulsion and hydrophobic interactions. SHMP can also reverse existing aggregates, highlighting its role in protein stabilization and its potential application in preventing or reversing protein aggregation in biotechnological systems. Conclusion In this study, we explore the effects of SHMP at millimolar concentrations on trypsin aggregation and structural stability at pH 6.0. The key findings revealed that low concentrations of SHMP (up to 1 mM) cause trypsin aggregation, while higher concentrations (6 mM and above) effectively reduced the aggregation. This concentration-dependent solubilization of trypsin aggregates was supported by fluorescence spectroscopy and circular dichroism (CD) data, which show restoration of the nativelike conformation at higher SHMP concentrations. The absence of amyloid-like structures, confirmed by CD, ThT assays, and TEM imaging, indicates that amyloid-like aggregation did not occur. The study identified the negatively charged phosphate groups in SHMP as central to these effects, preventing aggregation through charge–charge repulsion mechanisms. The ability of SHMP to reverse preformed aggregates highlights its potential for biotechnological applications in inclusion body solubilization and protein refolding.